cysteamine has been researched along with HIV Coinfection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clayette, P; Dormont, D; Fretier, P; Imbach, JL; Mialocq, P; Oiry, J; Puy, JY | 1 |
| Buondelmonte, C; Cafaro, A; Caputo, A; Castaldello, A; Dominici, S; Ensoli, B; Fraternale, A; Garaci, E; Magnani, M; Palamara, AT; Paoletti, MF; Sgarbanti, R; Tripiciano, A | 1 |
2 other study(ies) available for cysteamine and HIV Coinfection
| Article | Year |
|---|---|
NAC/MEA conjugate: a new potent antioxidant which increases the GSH level in various cell lines.
Topics: Acetylcysteine; Antioxidants; Astrocytes; CD4-Positive T-Lymphocytes; Cell Line; Cysteamine; Glutathione; HIV Infections; Humans; Indicators and Reagents; Macrophages; Monocytes; Prodrugs | 2001 |
Modulation of Th1/Th2 immune responses to HIV-1 Tat by new pro-GSH molecules.
Topics: Acetylcysteine; Adjuvants, Immunologic; AIDS Vaccines; Animals; Cysteamine; Epitope Mapping; Female; Glutathione; HIV Antibodies; HIV Infections; HIV-1; Immunity, Cellular; Immunoglobulin G; Immunoglobulin Isotypes; Immunologic Factors; Interferon-gamma; Interleukin-12; Interleukin-2; Mice; Mice, Inbred BALB C; Prodrugs; tat Gene Products, Human Immunodeficiency Virus; Th1 Cells; Th2 Cells | 2011 |